BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 24352453)

  • 1. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
    Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
    J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.
    Kwon DS; Angin M; Hongo T; Law KM; Johnson J; Porichis F; Hart MG; Pavlik DF; Tighe DP; Kavanagh DG; Streeck H; Addo MM; Kaufmann DE
    J Virol; 2012 Jun; 86(12):6586-94. PubMed ID: 22496237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs.
    Siewe B; Wallace J; Rygielski S; Stapleton JT; Martin J; Deeks SG; Landay A
    PLoS One; 2014; 9(4):e92934. PubMed ID: 24739950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.
    Porichis F; Kwon DS; Zupkosky J; Tighe DP; McMullen A; Brockman MA; Pavlik DF; Rodriguez-Garcia M; Pereyra F; Freeman GJ; Kavanagh DG; Kaufmann DE
    Blood; 2011 Jul; 118(4):965-74. PubMed ID: 21652684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
    J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ upregulates Δ42PD1 expression on human monocytes via the PI3K/AKT pathway.
    Cheng L; Tang X; Xu L; Zhang L; Shi H; Peng Q; Zhao F; Zhou Y; He Y; Wang H; Zhou B; Gao Z; Chen Z
    Immunobiology; 2019 May; 224(3):388-396. PubMed ID: 30846331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
    Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
    Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
    Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
    J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.